- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03624764
Assisted Promontofixation Using Glue Versus Promontofixation Using Threads (PROCOL) (PROCOL)
A Randomized Comparative Study of Assisted Promontofixation Using Glue Versus Promontofixation Using Threads
Study Overview
Status
Conditions
Detailed Description
Laparoscopic promontofixation is a surgical technique considered by some as the reference technique. Its difficulty of learning and the duration of operation are factors limiting its diffusion. The use of cyanoacrylate glue is proposed to simplify the procedure, without there being any comparative studies between the sutures over and the sizing of prosthetic reinforcements.
The main objective of the study is to compare the operative time of promontofixation by coelioscopy with suture using threads to promontofixation using glue.
Secondary objectives are the comparison between the two groups of complications per and postoperative, objective anatomical results and functional results of the tissue reaction judged by clinical examination (palpation) and ultrasound and direct cost.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Montpellier, France, 34070
- Clinique Beau Soleil
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age> 40 years
- Surgical indication of prolapse cure by promontofixation
- Valid social insurance
- French spoken and written
- Informed consent signed
- No exclusion criteria
Exclusion Criteria:
- Concomitant rectopexy
- Concomitant Hysterectomy
- Associated surgical procedure not compatible with measurement of operative time
- Refusal to participate in the study
- Pregnant or lactating woman (Article L 1121-5 of the french code of public health)
- Vulnerable persons (Article L 1121-6 of the french code of public health)
- Majors subject to legal protection or unable to express their consent (Article 1121-8 of the CSP)
- Participation in another protocol for less than 3 months
- Patient does not have all the inclusion criteria.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Promontofixation using glue
Patients in this arm will have a laparoscopic promontofixation using a biocompatible cyanoacrylate adhesive replacing some sutures to maintain the strips.
|
The technique involves implanting a prosthetic tissue (tape) between the bladder and the vagina, suspending the cervix or the vagina affectionately, associated or not with a posterior strip placed between the rectum and the vagina fixed on the small pelvis muscles.
Each strip is held by the surgical glue (cyanoacrylate biocompatible adhesive)
|
|
Active Comparator: Promontofixation using threads
Patients in this arm will have a laparoscopic promontofixation using sutures with threads to maintain the strips.
|
The technique involves implanting a prosthetic tissue (tape) between the bladder and the vagina, suspending the cervix or the vagina affectionately, associated or not with a posterior strip placed between the rectum and the vagina fixed on the small pelvis muscles.
Each strip is held by sutures with threads
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operative time
Time Frame: one day
|
The time elapsed between incision and closure
|
one day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Collection of intra-operative complications
Time Frame: one day
|
Collection of all the complications during the surgery (visceral wound, peroperative bleeding, other)
|
one day
|
|
Collection of per-operative complications
Time Frame: one day
|
Collection of the per-operative complications: pain at day 0 and day 1 (using the visual analog scale), urinary retention, postoperative haemorrhage or hematoma, fever> 38 ° 48 h after surgery, other complication
|
one day
|
|
Collection of complications at 6 weeks
Time Frame: 6 weeks
|
Pain by the Visuel Analog Scale, emergency consultation or generalist, rehospitalization / Reintervention, other complications
|
6 weeks
|
|
Tolerance of the prosthesis
Time Frame: 6 weeks
|
Classification of the complications related to the insertion of protheses (from the International Urogynecological Association)
|
6 weeks
|
|
Tolerance of the prosthesis
Time Frame: 6 months
|
Classification of the complications related to the insertion of protheses (from the International Urogynecological Association)
|
6 months
|
|
Tolerance of the prosthesis
Time Frame: 12 months
|
Classification of the complications related to the insertion of protheses (from the International Urogynecological Association)
|
12 months
|
|
Objective anatomical results at 6 weeks
Time Frame: Before surgery
|
International Continence Society - Pelvic organe Prolapse - Quantification (POP Q scale): stage 0 (no prolapse is demonstrated) to stage 4 (vaginal eversion is essentially complete)
|
Before surgery
|
|
Objective anatomical results at 6 months
Time Frame: 6 months after surgery
|
International Continence Society - Pelvic organe Prolapse - Quantification (POP Q scale): stage 0 (no prolapse is demonstrated) to stage 4 (vaginal eversion is essentially complete)
|
6 months after surgery
|
|
Objective anatomical results at 12 month
Time Frame: 12 months after surgery
|
International Continence Society - Pelvic organe Prolapse - Quantification (POP Q scale): stage 0 (no prolapse is demonstrated) to stage 4 (vaginal eversion is essentially complete)
|
12 months after surgery
|
|
Quality of life: pelvic floor distress
Time Frame: Before the surgery
|
The Pelvic Floor Distress Inventory-20 questionnary: it is both a symptom inventory and a measure of the degree of bother and distress (quality-of-life) caused by pelvic floor symptoms.The PFDI-20 includes 20 questions and 3 scales.
Each of the 3 scales is scored from 0 (least distress) to 100 (greatest distress).
The sum of the scores of these 3 scales serves as the overall summary score of the PFDI-20 and ranges from 0 - 300.
The 3 scales include questions taken from the following widely used outcome measures: Urinary Distress Inventory - 6 questions, Pelvic Organ Prolapse Distress Inventory - 6 questions, and Colorectal-Anal Distress Inventory - 8 questions
|
Before the surgery
|
|
Quality of life: pelvic floor distress
Time Frame: 6 months after the surgery
|
The Pelvic Floor Distress Inventory-20 questionnary.
The PFDI-20 includes 20 questions and 3 scales.
Each of the 3 scales is scored from 0 (least distress) to 100 (greatest distress).
The sum of the scores of these 3 scales serves as the overall summary score of the PFDI-20 and ranges from 0 - 300.
The 3 scales include questions taken from the following widely used outcome measures: Urinary Distress Inventory - 6 questions, Pelvic Organ Prolapse Distress Inventory - 6 questions, and Colorectal-Anal Distress Inventory - 8 questions
|
6 months after the surgery
|
|
Quality of life: pelvic floor distress
Time Frame: 12 months after the surgery
|
The Pelvic Floor Distress Inventory-20 questionnary.
The PFDI-20 includes 20 questions and 3 scales.
Each of the 3 scales is scored from 0 (least distress) to 100 (greatest distress).
The sum of the scores of these 3 scales serves as the overall summary score of the PFDI-20 and ranges from 0 - 300.
The 3 scales include questions taken from the following widely used outcome measures: Urinary Distress Inventory - 6 questions, Pelvic Organ Prolapse Distress Inventory - 6 questions, and Colorectal-Anal Distress Inventory - 8 questions
|
12 months after the surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Christophe Courtieu, Clinqieu Beau Soleil
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016- A01387-44
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prolapse
-
Fundació Institut de Recerca de l'Hospital de la...Carlos III Health Institute; Ministry of Science and Innovation, SpainCompletedProlapse; Female | Prolapse Genital | Prolapse UterovaginalSpain
-
Hospital Mutua de TerrassaGermans Trias i Pujol Hospital; Hospital Arnau de Vilanova; Fundació Institut...RecruitingProlapse; Female | Prolapse Genital | Prolapse UterovaginalSpain
-
Rennes University HospitalCompleted
-
Centre Hospitalier Universitaire de NīmesUniversity Hospital, Lille; Centre Hospitalier de La Rochelle; Kremlin-Bicetre... and other collaboratorsRecruitingProlapse; Female | Prolapse Uterovaginal | Prolapse; CervixFrance
-
NICHD Pelvic Floor Disorders NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingPelvic Organ Prolapse | Pelvic Organ Prolapse Vaginal Surgery | Pelvic Organ Prolapse, Patient Education | Pelvic Organ Prolapse (POP)United States
-
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training...CompletedVaginal Vault Prolapse | Pelvic Floor ProlapseTurkey
-
Ain Shams UniversityCompletedUterovaginal and Vaginal Vault ProlapseEgypt
-
Centre Hospitalier Universitaire de NīmesCompletedVaginal ProlapseFrance
-
The Methodist Hospital Research InstituteUnknownVaginal Vault Prolapse | Post-Hysterectomy Vaginal Vault Prolapse | Prolapse, VaginalUnited States
-
Manchester University NHS Foundation TrustRecruitingProlapse; Female | Prolapse, VaginalUnited Kingdom
Clinical Trials on Laparostopic promontofixation using surgical glue
-
Kuopio University HospitalNorth Karelia Central Hospital; Paijat-Hame Hospital DistrictCompleted
-
Mansoura UniversityCompleted
-
Hospital de Olhos Sadalla Amin GhanemCompletedPterygium | PrimaryBrazil
-
Riga East Clinical University HospitalPauls Stradins Clinical University Hospital; University of LatviaActive, not recruitingQuality of Life | Female Sexual Dysfunction (FSD) | Urinary Incontinence , Stress | Pelvic Organ Prolapse (POP) | Urinary Incontinence (UI)Latvia
-
DuomedCompletedInguinal HerniaBelgium
-
University Hospital OstravaRecruitingAdult Patients With Mid-term or Long-term Venous AccessCzechia
-
First Affiliated Hospital of Ningbo UniversityThe First Affiliated Hospital of Xinxiang Medical CollegeEnrolling by invitationUnilateral Meniscus Tear of the Knee JointChina
-
Ain Shams UniversityUnknown
-
Hospices Civils de LyonVitalitecCompletedMedial and/or Anterior Genital ProlapseFrance